Toward the World Code Against Cancer

Journal of Global Oncology
Carolina EspinaJoachim Schüz

Abstract

Overwhelmed by an abundance of often confusing, ambiguous, or apparently contradictory messages on disease prevention in today's multiple media streams, the general public would surely value authoritative, clear, and evidence-based instructions on how to actively contribute to the reduction of their cancer risk. The European Code Against Cancer is a set of 12 recommendations for individuals on how to reduce cancer risk. The Code carries the authority and reliability of expert scientists working under the coordination of the International Agency for Research on Cancer, the cancer research agency of the WHO. The Code's messages are aimed at individuals and have been enthusiastically promoted by European cancer associations. The experience of developing and promoting the European Code has generated interest in developing analogous recommendations for other regions of the world. Under the overall umbrella of a World Code Against Cancer using the same International Agency for Research on Cancer methodology, regional Codes could be developed, focused on regions sufficiently large and distinct to merit development of versions adapted to regional differences in risk factors and cancer patterns. Consideration of such an adapted model il...Continue Reading

References

Oct 10, 2003·Journal of Occupational and Environmental Medicine·Omur Cinar ElciMustafa Dosemeci
Jun 13, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B WangP Boffetta
May 1, 2013·The Lancet Oncology·Paul E GossGustavo Azenha
Apr 5, 2014·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·D Maxwell ParkinAhmedin Jemal
Apr 16, 2014·The Lancet Oncology·Paul E GossArlene Chan
Dec 4, 2014·The Lancet Oncology·Melina ArnoldIsabelle Soerjomataram
Jun 4, 2015·The New England Journal of Medicine·Béatrice Lauby-SecretanUNKNOWN International Agency for Research on Cancer Handbook Working Group
Jul 15, 2015·Cancer Epidemiology·Joachim SchüzUNKNOWN Working Groups of Scientific Experts
Jun 20, 2016·The Lancet Oncology·Dana LoomisUNKNOWN International Agency for Research on Cancer Monograph Working Group
Jun 24, 2016·Eastern Mediterranean Health Journal = La Revue De Santé De La Méditerranée Orientale = Al-Majallah Al-ṣiḥḥīyah Li-sharq Al-mutawassiṭ·R DenholmA C Olsson
Jul 30, 2016·The Lancet Global Health·Martyn PlummerSilvia Franceschi
Sep 30, 2016·Cancer Epidemiology·Mónica S SierraDavid Forman
Sep 30, 2016·Cancer Epidemiology·M Isabel IzarzugazaMónica S Sierra
Mar 8, 2017·Cancer Epidemiology·Ivana KulhánováIsabelle Soerjomataram
Nov 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J B WangP Boffetta

❮ Previous
Next ❯

Citations

Dec 26, 2018·Molecular Oncology·Joachim SchüzChristopher P Wild
May 6, 2019·Environmental Geochemistry and Health·Daniel R S MiddletonJoachim Schüz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.